Niagen Bioscience Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Niagen Bioscience Inc.
Former names: ChromaDex Corp. Cody Resources, INC.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2833 — Medicinal Chemicals & Botanical Products
Jurisdiction of incorporation: Delaware
Headquarters city: LOS Angeles
Headquarters state / province: California
Headquarters country: United States
Fiscal year end: December
Ticker symbol: NAGE
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001386570
EIN: 26-2940963

Board of directors

Follow this board

Ann Cohen · Director
Since 2023
Frank L. Jaksch Jr. · Director
Since 2023
Hamed Shahbazi · Director
Since 2023
Kristin Patrick · Director
Since 2023
Li Ka Shing · Director
Since 2023
Robert N. Fried · Director · Chief Executive Officer
Since 2023
Steven D. Rubin · Director Overboarded
Since 2023
Wang Yu Gary Ng · Director
Since 2023
Wing Tak Wendy Yu · Director
Since 2023

Chief executives

Robert N. Fried · Chief Executive Officer

Dates unknown

Director election results

Annual meeting of June 24, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

3 of this board's directors also sit on 8 other boards. 4 are in the same sector.

Shared director Other board Same sector

Cocrystal Pharma Inc. Same sector
via Steven D. Rubin
Eloxx Pharmaceuticals Inc. Same sector
via Steven D. Rubin
Entera Bio Ltd. Same sector
via Steven D. Rubin
Laird Superfood Inc.
via Kristin Patrick
OPKO Health Inc. Same sector
via Steven D. Rubin
Red Violet Inc.
via Steven D. Rubin
Super League Enterprise Inc.
via Kristin Patrick
The Metals Royalty Company Inc.
via Hamed Shahbazi

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $45,616; 2 purchases by 1 insider
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Jun 30, 2026	Robert N. Fried Director, Officer (Chief Executive Officer)	Grant or award	+1,106	$2.71	$2,997
Jun 30, 2026	Lopez Carlos Luis Officer (SVP, General Counsel)	Grant or award	+2,314	$2.71	$6,271
Jun 30, 2026	Pamir Ozan Officer (Chief Financial Officer)	Grant or award	+4,255	$2.71	$11,531
Apr 24, 2026	Robert N. Fried Director, Officer (Chief Executive Officer)	Option exercise	+20,000	$2.61	$52,200
Nov 14, 2025	Pamir Ozan Officer (Chief Financial Officer)	Open-market purchase	+4,465	$6.81	$30,406
Nov 14, 2025	Pamir Ozan Officer (Chief Financial Officer)	Open-market purchase	+2,220	$6.85	$15,210
Apr 9, 2025	Robert N. Fried Director, Officer (Chief Executive Officer)	Option exercise	+66,667	$3.30	$220,001
Mar 7, 2025	Lopez Carlos Luis Officer (SVP, General Counsel)	Open-market purchase	+273	$7.86	$2,146
Dec 13, 2024	Frank L. Jaksch Jr. Director	Option exercise	+50,001	$3.66	$183,004
Dec 13, 2024	Frank L. Jaksch Jr. Director	Open-market sale	−37,161	$6.19	$230,027
Nov 22, 2024	Pamir Ozan Officer (Chief Financial Officer)	Open-market purchase	+2,907	$7.36	$21,397
Aug 23, 2024	Kristin Patrick Director	Option exercise	+3,000	$1.64	$4,920
Aug 23, 2024	Kristin Patrick Director	Option exercise	+20,000	$1.67	$33,400
Aug 23, 2024	Kristin Patrick Director	Open-market sale	−23,000	$3.57	$82,110
Aug 20, 2024	Li Ka Shing 10% owner	Open-market sale	−11,408,715	—	—

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Niagen Bioscience Inc.

Who is the CEO of Niagen Bioscience Inc.?

Robert N. Fried is Niagen Bioscience Inc.'s Chief Executive Officer.

How many directors are on Niagen Bioscience Inc.'s board?

Niagen Bioscience Inc.'s board has 9 directors: Ann Cohen, Frank L. Jaksch Jr., Hamed Shahbazi, Kristin Patrick, Li Ka Shing, Robert N. Fried, Steven D. Rubin, Wang Yu Gary Ng and Wing Tak Wendy Yu.

Are Niagen Bioscience Inc. insiders buying or selling shares?

Over the last 12 months, Niagen Bioscience Inc. insiders bought $45,616 of shares in 2 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Niagen Bioscience Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="niagen-bioscience-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.